Biguanides (e.g. metformin) have limited efficacy to lower hyperglycemia and exert their effects by decreasing carbohydrate absorption from the intestine, hepatic gluconeogenesis and glucagon secretion from the pancreas. This evidence concerns the gene GCG and Hyperglycemia.